Get the Stockscreener App
9.33
1.79%
-0.17
After Hours:
9.38
0.05
+0.54%
Zevra Therapeutics Inc Stock (ZVRA) Forecast
The Zevra Therapeutics Inc (ZVRA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.1147, representing a -55.90% decrease from the current price of $9.33. The highest analyst price target is $4.5147, and the lowest is $3.7147.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ZVRA Price Target
Average 5.3684
(-42.46% Downside)
Is Zevra Therapeutics Inc (ZVRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.50 | Neutral |
| STOCH(9,6) | 83.38 | Sell |
| STOCHRSI(14) | 50.43 | Neutral |
| MACD(12,26) | 0.322 | Buy |
| ADX(14) | 24.83 | Neutral |
| William %R | -22.40 | Neutral |
| CCI(14) | 67.52 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.1625
Buy
|
9.2242
Buy
|
| MA20 |
8.9513
Buy
|
8.9742
Buy
|
| MA50 |
8.3216
Buy
|
8.4106
Buy
|
| MA100 |
7.6365
Buy
|
7.6897
Buy
|
| MA200 |
6.4253
Buy
|
6.8367
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ZVRA could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ZVRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.5 indicates that ZVRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 83.38 indicates that ZVRA is oversold. This means that ZVRA price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.43 indicates that ZVRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.83 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 67.52 indicates that ZVRA is still overbought but not to an extreme extent.
Long-term ZVRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Zevra Therapeutics Inc financial reports and earnings history, Zevra Therapeutics Inc (ZVRA) stock could reach $4.5147 by 2030, $3.8464 by 2040 and $3.2652 by 2050. See the projected annual prices until 2050 of the Zevra Therapeutics Inc stock below:
- Zevra Therapeutics Inc (ZVRA) is expected to reach an average price of $3.3176 in 2035, with a high prediction of $4.4765 and a low estimate of $3.0076. This indicates an $-64.44% rise from the last recorded price of $9.33.
- Zevra Therapeutics Inc (ZVRA) stock is projected to chart a bullish course in 2040, with an average price target of $3.6864, representing an $-60.49% surge from its current level. The forecast ranges from a conservative $2.0516 to a sky-high $3.8464.
- Our analysts predict Zevra Therapeutics Inc (ZVRA) to jump -70.85% by 2045, soaring from $2.5096 to an average price of $2.7196, potentially reaching $3.5937. While $2.5096 is the low estimate, the potential upside is significant.
- Zevra Therapeutics Inc (ZVRA) stock is expected to climb by 2050, reaching an average of $2.0975, a $-77.52% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.2652 and $1.7202, respectively, highlighting the market's uncertainty.
Zevra Therapeutics Inc Stock (ZVRA) Year by Year Forecast
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2025
Zevra Therapeutics Inc Stock (ZVRA) is expected to reach an average price of $5.3684 in 2025, with a high prediction of $7.0867 and a low estimate of $3.65. This indicates an -42.46% fall from the last recorded price of $9.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.9547 | $3.7147 | $4.5147 | -57.61% |
| February, 2025 | $4.7651 | $3.6948 | $4.8001 | -48.93% |
| March, 2025 | $6.3556 | $4.4255 | $6.4856 | -31.88% |
| April, 2025 | $5.5963 | $5.4061 | $6.9558 | -40.02% |
| May, 2025 | $6.4367 | $5.4365 | $7.0867 | -31.01% |
| June, 2025 | $5.8072 | $5.5771 | $6.907 | -37.76% |
| July, 2025 | $4.3278 | $4.1978 | $6.1575 | -53.61% |
| August, 2025 | $4.40 | $3.65 | $4.615 | -52.84% |
| September, 2025 | $5.881 | $4.2502 | $6.041 | -36.97% |
| October, 2025 | $5.0022 | $3.822 | $5.9812 | -46.39% |
| November, 2025 | $5.1432 | $4.4625 | $5.5625 | -44.87% |
| December, 2025 | $4.3544 | $4.2992 | $5.8637 | -53.33% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2026
The predicted value for Zevra Therapeutics Inc (ZVRA) in 2026 is set at an average of $5.1717. Estimates vary from a peak of $6.8935 to a trough of $3.45, indicating an -44.57% surge from the present price of $9.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.4254 | $4.1949 | $4.6247 | -52.57% |
| February, 2026 | $4.6764 | $4.3506 | $5.1059 | -49.88% |
| March, 2026 | $4.4674 | $4.3569 | $5.1471 | -52.12% |
| April, 2026 | $3.9486 | $3.7783 | $4.6976 | -57.68% |
| May, 2026 | $3.9496 | $3.4996 | $4.3193 | -57.67% |
| June, 2026 | $4.6905 | $3.9098 | $4.8905 | -49.73% |
| July, 2026 | $5.5318 | $4.231 | $6.7615 | -40.71% |
| August, 2026 | $5.3927 | $5.2121 | $5.8126 | -42.20% |
| September, 2026 | $6.694 | $5.243 | $6.8935 | -28.25% |
| October, 2026 | $5.415 | $5.205 | $6.2942 | -41.96% |
| November, 2026 | $4.1359 | $4.0057 | $5.1052 | -55.67% |
| December, 2026 | $4.9007 | $3.45 | $5.1223 | -47.47% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Zevra Therapeutics Inc (ZVRA) is $4.9358, with a high forecast of $6.5673 and a low forecast of $3.3043. This indicates an -47.10% decrease from the last price of $9.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.8022 | $4.4922 | $5.8415 | -48.53% |
| February, 2027 | $4.4437 | $3.6229 | $5.3637 | -52.37% |
| March, 2027 | $4.9355 | $4.354 | $5.6655 | -47.10% |
| April, 2027 | $4.287 | $4.1013 | $4.9259 | -54.05% |
| May, 2027 | $4.6085 | $3.9974 | $4.7085 | -50.61% |
| June, 2027 | $4.6703 | $4.1603 | $4.9088 | -49.94% |
| July, 2027 | $4.1118 | $3.9718 | $4.9507 | -55.93% |
| August, 2027 | $3.8932 | $3.5825 | $4.2521 | -58.27% |
| September, 2027 | $4.1751 | $3.3043 | $4.3851 | -55.25% |
| October, 2027 | $4.3865 | $4.0365 | $4.6958 | -52.98% |
| November, 2027 | $5.138 | $4.3269 | $6.5673 | -44.93% |
| December, 2027 | $6.2799 | $5.0495 | $6.5199 | -32.69% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2028
In 2028, Zevra Therapeutics Inc (ZVRA) is projected to reach an average price of $4.9144, with a high projection of $6.7002 and a low estimate of $3.1286. This indicates an -47.33% fall from the last price of $9.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.5213 | $5.1913 | $6.7002 | -40.82% |
| February, 2028 | $4.2428 | $4.2228 | $5.9017 | -54.53% |
| March, 2028 | $4.1533 | $3.8135 | $4.4932 | -55.48% |
| April, 2028 | $4.8115 | $3.25 | $4.9224 | -48.43% |
| May, 2028 | $3.4339 | $3.4239 | $5.642 | -63.19% |
| June, 2028 | $4.2459 | $3.4244 | $5.1649 | -54.49% |
| July, 2028 | $4.3078 | $3.9978 | $5.4674 | -53.83% |
| August, 2028 | $4.0903 | $3.7998 | $4.3883 | -56.16% |
| September, 2028 | $4.1823 | $3.9408 | $4.7118 | -55.17% |
| October, 2028 | $4.3442 | $3.9637 | $4.7542 | -53.44% |
| November, 2028 | $3.4267 | $3.3867 | $4.3847 | -63.27% |
| December, 2028 | $3.3686 | $3.1286 | $3.9286 | -63.89% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2029
The 2029 price forecast for Zevra Therapeutics Inc Stock (ZVRA) is $4.7785 on average, with a high prediction of $6.507 and a low estimate of $3.05. This represents an -48.78% decrease from the previous price of $9.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.3011 | $3.1091 | $4.5011 | -53.90% |
| February, 2029 | $5.163 | $3.8421 | $6.373 | -44.66% |
| March, 2029 | $5.015 | $4.8241 | $5.5735 | -46.25% |
| April, 2029 | $5.857 | $4.856 | $6.507 | -37.22% |
| May, 2029 | $4.9894 | $4.9794 | $6.3279 | -46.52% |
| June, 2029 | $3.7514 | $3.6214 | $5.5799 | -59.79% |
| July, 2029 | $3.80 | $3.05 | $4.015 | -59.27% |
| August, 2029 | $4.8631 | $3.6506 | $5.4425 | -47.88% |
| September, 2029 | $4.4055 | $3.2249 | $4.9737 | -52.78% |
| October, 2029 | $4.8186 | $3.8661 | $5.0586 | -48.35% |
| November, 2029 | $3.761 | $3.7054 | $5.2692 | -59.69% |
| December, 2029 | $3.8335 | $3.6023 | $4.0316 | -58.91% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2030
Zevra Therapeutics Inc Stock (ZVRA) is expected to reach an average price of $4.5819 in 2030, with a high forecast of $6.3137 and a low forecast of $2.85. This signifies an -50.89% decrease from the last price of $9.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3965 | $3.7591 | $4.5147 | -52.88% |
| February, 2030 | $3.839 | $3.759 | $4.5578 | -58.85% |
| March, 2030 | $3.3614 | $3.1908 | $3.8796 | -63.97% |
| April, 2030 | $3.3639 | $2.9139 | $3.7333 | -63.95% |
| May, 2030 | $3.792 | $3.3245 | $4.3063 | -59.36% |
| June, 2030 | $4.9494 | $3.6476 | $6.1788 | -46.95% |
| July, 2030 | $5.1825 | $4.6301 | $5.2314 | -44.45% |
| August, 2030 | $6.1149 | $4.7431 | $6.3137 | -34.46% |
| September, 2030 | $4.8374 | $4.6274 | $5.7155 | -48.15% |
| October, 2030 | $3.6204 | $3.4292 | $4.528 | -61.20% |
| November, 2030 | $4.3015 | $2.85 | $4.5226 | -53.90% |
| December, 2030 | $4.2044 | $3.8944 | $5.2429 | -54.94% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):